Xtant Medical Holdings, Inc.’s XTNT share price has surged by 10.99%, which has investors questioning if this is right time to sell.

CGBIO, a South Korea-based company, earned the FDA’s investigational device exemption approval for its Novosis putty for spinal fusions. The bone graft incorporates rhBMP-2 and is designed to enhance ...